跳至主要内容
临床试验/CTRI/2022/04/041787
CTRI/2022/04/041787进行中(未招募)未知

AN OPEN LABEL NON-RANDOMIZED CLINICAL TRIAL TO EVALUATE THE ROLE OF INDIVIDUALIZED HOMOEOPATHIC MEDICINE IN MANAGEMENT OF PATIENTS OF PSORIASIS

ational Institute of Homoeopathy0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patient suffering from psoriasis since at least 3 months. 2. Both male and female patients. 3. Age- 18-60 years. 4. Patients willing to participate in the study and giving written informed consent.

排除标准

  • 1. Patient who are unwilling to give consent.
  • 2. Psoriasis with complications like erythroderma and pustules.
  • 3. Diagnosed cases of unstable psychiatric complaints or other systemic diseases affecting quality of life.
  • 4. Pregnant and lactating women.
  • 5. Self reported immune compromised conditions.
  • 6. Substance abuse and or dependence
  • 7. Taking homeopathic treatment for any chronic diseases within last 6 months.

研究者

发起方
ational Institute of Homoeopathy

相似试验